60 DEGREES PHARMACEUTICALS, INC. Logo

60 DEGREES PHARMACEUTICALS, INC.

Develops medicines for tropical diseases, including ARAKODA for malaria prevention.

SXTP | US

Overview

Corporate Details

ISIN(s):
US83006G1040
LEI:
Country:
United States of America
Address:
1025 CONNECTICUT AVENUE NW, 20036 WASHINGTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

60 Degrees Pharmaceuticals, Inc., established in 2010, is a specialty pharmaceutical company focused on the development and commercialization of medicines to treat and prevent infectious diseases. The company primarily targets tropical diseases with significant unmet medical needs, such as malaria and dengue fever. Its key commercial product is ARAKODA® (tafenoquine), a therapy for malaria prevention. The company's mission is to develop innovative therapeutic solutions to improve the quality of life for affected populations worldwide, including travelers to endemic regions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all 60 DEGREES PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 60 DEGREES PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 60 DEGREES PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

TAIKO PHARMACEUTICAL CO., LTD. Logo
Manufactures OTC gastrointestinal medicine and leading infection control products.
Japan
4574
TAKARA BIO INC. Logo
Provides life science research tools, gene therapies, and CDMO services for improving human health.
Japan
4974
TAKEDA PHARMACEUTICAL CO LTD Logo
R&D-driven biopharma developing treatments for oncology, rare diseases, neuroscience, and GI.
United States of America
TAK
Takeda Pharmaceutical Company Limited Logo
R&D-driven biopharma creating medicines for Oncology, Rare Diseases, GI, and Neuroscience.
Japan
4502
TALPHERA, INC. Logo
Develops therapies for acute pain and anticoagulants for medically supervised settings.
United States of America
TLPH
Tango Therapeutics, Inc. Logo
Developing precision oncology therapies for genetically-defined patients via synthetic lethality.
United States of America
TNGX
Tarsus Pharmaceuticals, Inc. Logo
Develops novel therapies for eye care, including the first FDA-approved Demodex blepharitis drug.
United States of America
TARS
TAUNS Laboratories, Inc. Logo
Develops and sells in vitro diagnostics and research reagents, like antigen tests, globally.
Japan
197A
Taysha Gene Therapies, Inc. Logo
Developing AAV-based gene therapies for rare, severe monogenic diseases of the central nervous system.
United States of America
TSHA
Tchaikapharma High Quality Medicines AD Logo
Develops and makes affordable generic drugs for cardiovascular & metabolic diseases.
Bulgaria
THQM

Talk to a Data Expert

Have a question? We'll get back to you promptly.